Artificial Pancreas Device System Market
Artificial Pancreas Device System Market - Global Industry Assessment & Forecast
#
Pages:
140
2022
Feb - 2022
VMR-1335
Segments Covered
By
Device Threshold Suspended Device System, CTR System, CTT System
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 107.35 Million |
 Revenue 2030:
|
USD 285.40 Million |
 Revenue CAGR
(2023 - 2030): |
13.00% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
Europe |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Artificial Pancreas Device System Market by Device by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Artificial Pancreas Device System supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:
- Artificial Pancreas Device System market size at regional and country level
- Key industry players and their market share and Artificial Pancreas Device System market-specific sales/revenue
- Understanding of the Artificial Pancreas Device System supply chain and overall ecosystem
Data Triangulation and Market Size Estimations
After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Artificial Pancreas Device System market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market. The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Artificial Pancreas Device System market.
Vantage Market
Research | 17-Feb-2022
FAQ
Frequently Asked Question
What is the global demand for Artificial Pancreas Device System in terms of revenue?
-
The global Artificial Pancreas Device System valued at USD 107.35 Million in 2022 and is expected to reach USD 285.40 Million in 2030 growing at a CAGR of 13.00%.
Which are the prominent players in the market?
-
The prominent players in the market are Medtronic Plc., Medtrum Technologies Inc., Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Inc., Bigfoot Biomedical, Insulet Corporation, Pancreum, Inc., TypeZero Technologies, Inc., DreaMed Diabetes Ltd, and Inreda Diabetic BV..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 13.00% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Artificial Pancreas Device System include
- Increasing Prevalence of Diabetes and Geriatric Population Globally
Which region accounted for the largest share in the market?
-
Europe was the leading regional segment of the Artificial Pancreas Device System in 2022.
